On February 2, 2026, the Taiwan Food and Drug Administration (TFDA), under the Ministry of Health and Welfare, announced a revision to the annex of the Documentation Required for Case-by-Case Review of Applications for the Use of Human Cell-Derived Exosomes in Cosmetics. The revised annex takes effect immediately upon the date of announcement.

January 12, 2026, the New Jersey Senate has passed Bill S1221, officially titled the Protecting Against Forever Chemicals Act, which introduces a ban on the sale of cosmetic products containing intentionally added per- and polyfluoroalkyl substances (PFAS), effective in 2028.

The Labeling of Hazardous Art Materials Act (LHAMA) requires all art materials to be evaluated for chronic health hazards. Materials posing such risks must have appropriate warning labels. This law applies to all art materials, not just those for children. Under U.S. Consumer Product Safety Commission (CPSC) regulations (16 CFR §1500.14(b)(8)), art materials must undergo LHAMA assessment and labeling in accordance with ASTM D4236.

On January 15, 2025, China’s National Institutes for Food and Drug Control (NIFDC) issued a notice announcing the release of three draft cosmetic standards aimed at further enhancing the country’s technical framework for cosmetics. The drafts are now open for public consultation, with the deadline for submitting comments set for February 24, 2026.